# Transcode Therapeutics, Inc.: Form 8-K, filed May 22, 2026

- Company: [Transcode Therapeutics, Inc.](/companies/rnaz.md) (CIK 1829635)
- Form: 8-K
- Filed: 2026-05-22
- Accepted by EDGAR: May 22, 2026, 20:15 ET
- Period: 2026-05-19
- Accession: 0001104659-26-065728
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1829635/000110465926065728/tm2615385d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1829635/000110465926065728/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1829635/000110465926065728/tm2615385d1_8k.htm

Filed May 22, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-065728. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.